-
公开(公告)号:US20080131507A1
公开(公告)日:2008-06-05
申请号:US11906303
申请日:2007-10-01
申请人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
发明人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
IPC分类号: A61K9/20 , A61K31/192
CPC分类号: A61K9/2013 , A61K9/2031 , A61K9/2054 , A61K31/192
摘要: A method of forming a tablet includes the steps of pre-blending an active pharmaceutical ingredient susceptible to tackiness and a blending additive with a first mixing effort to form a pre-blend mixture, wherein the first mixing effort and a second mixing effort, resulting from mixing at least one excipient with the pre-blend mixture, form a blend suitable for direct compression and compressing the blend to form the tablet. One way of achieving the first mixing effort is to pre-blend for an extended period of time. The method allows for directly compressing the blend without the need for a granulation step or roller compression. One such active pharmaceutical ingredient susceptible to tackiness is ibuprofen.
摘要翻译: 形成片剂的方法包括以下步骤:将具有粘性的活性药物成分和混合添加剂预先混合以形成预混物混合物,其中第一混合力和第二混合力由 将至少一种赋形剂与预混物混合物混合,形成适于直接压缩和压缩混合物以形成片剂的共混物。 实现第一次混合努力的一种方式是预混合一段较长的时间。 该方法允许直接压缩共混物,而不需要造粒步骤或辊压缩。 易于粘性的一种这样的活性药物成分是布洛芬。
-
公开(公告)号:US20060068009A1
公开(公告)日:2006-03-30
申请号:US11238802
申请日:2005-09-29
申请人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
发明人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
IPC分类号: A61K9/22
CPC分类号: A61K9/2031 , A61K9/2013 , A61K9/2054
摘要: The present invention is a solid dosage form for oral administration of ibuprofen comprising a modified release formulation of ibuprofen which provides an immediate burst effect and thereafter a sustained release of sufficient ibuprofen to maintain blood levels at least 6.4 μg/ml over an extended period of at least 8 hours following administration of a single dose. The dosage form releases ibuprofen at a rate sufficient to initially deliver a effective amount of ibuprofen within about 2.0 hours following administration. The dosage form then subsequently delivers the remaining amount of ibuprofen at a relatively constant rate sufficient to maintain a level of ibuprofen over a predetermined delivery period of for at least 8 hours.
摘要翻译: 本发明是用于口服给予布洛芬的固体剂型,其包含布洛芬的改良释放制剂,其提供立即爆发作用,然后持续释放足够的布洛芬以在长时间内维持血液水平至少为6.4mug / ml 给予单剂后至少8小时。 剂型以足以在给药后约2.0小时内最初递送有效量的布洛芬的速率释放布洛芬。 然后剂型随后以相对恒定的速率递送剩余量的布洛芬,足以将布洛芬的水平维持在预定的输送期间至少8小时。
-
公开(公告)号:US20100143466A1
公开(公告)日:2010-06-10
申请号:US12706429
申请日:2010-02-16
申请人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
发明人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
IPC分类号: A61K9/20 , A61K31/192
CPC分类号: A61K9/2054 , A61K9/2009 , A61K9/2013 , A61K9/2031 , A61K9/2059 , A61K31/192 , A61K47/02 , A61K47/183 , A61K47/38
摘要: The present invention is a solid dosage form for oral administration of ibuprofen comprising a modified release formulation of ibuprofen which provides an immediate burst effect and thereafter a sustained release of sufficient ibuprofen to maintain blood levels at least 6.4 μg/ml over an extended period of at least 8 hours following administering of a single dose.
摘要翻译: 本发明是用于口服施用布洛芬的固体剂型,其包含布洛芬的改良释放制剂,其提供立即的爆发作用,然后持续释放足够的布洛芬以在长时间内维持血液水平至少为6.4μg/ ml 在给予单次剂量后至少8小时。
-
公开(公告)号:US20070077297A1
公开(公告)日:2007-04-05
申请号:US11633322
申请日:2006-12-04
申请人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
发明人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
IPC分类号: A61K31/192 , A61K9/20
CPC分类号: A61K9/2054 , A61K9/2009 , A61K9/2013 , A61K9/2031 , A61K9/2059 , A61K31/192 , A61K47/02 , A61K47/183 , A61K47/38
摘要: The present invention is a solid dosage form for oral administration of ibuprofen comprising a modified release formulation of ibuprofen which provides an immediate burst effect and thereafter a sustained release of sufficient ibuprofen to maintain blood levels at least 6.4 μg/ml over an extended period of at least 8 hours following administering of a single dose.
摘要翻译: 本发明是用于口服给予布洛芬的固体剂型,其包含布洛芬的改良释放制剂,其提供立即爆发作用,然后持续释放足够的布洛芬以在长时间内维持血液水平至少为6.4mug / ml 在给予单次剂量后至少8小时。
-
公开(公告)号:US09028869B2
公开(公告)日:2015-05-12
申请号:US12706429
申请日:2010-02-16
申请人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
发明人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
CPC分类号: A61K9/2054 , A61K9/2009 , A61K9/2013 , A61K9/2031 , A61K9/2059 , A61K31/192 , A61K47/02 , A61K47/183 , A61K47/38
摘要: The present invention is a solid dosage form for oral administration of ibuprofen comprising a modified release formulation of ibuprofen which provides an immediate burst effect and thereafter a sustained release of sufficient ibuprofen to maintain blood levels at least 6.4 μg/ml over an extended period of at least 8 hours following administering of a single dose.
摘要翻译: 本发明是用于口服施用布洛芬的固体剂型,其包含布洛芬的改良释放制剂,其提供立即的爆发作用,然后持续释放足够的布洛芬以在长时间内维持血液水平至少为6.4μg/ ml 在给予单次剂量后至少8小时。
-
公开(公告)号:US07749537B2
公开(公告)日:2010-07-06
申请号:US11906303
申请日:2007-10-01
申请人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
发明人: Michael Hite , Cathy Federici , Alan Brunelle , Stephen Turner
IPC分类号: A61K9/20 , A61K31/192
CPC分类号: A61K9/2013 , A61K9/2031 , A61K9/2054 , A61K31/192
摘要: A method of forming a tablet includes the steps of pre-blending an active pharmaceutical ingredient susceptible to tackiness and a blending additive with a first mixing effort to form a pre-blend mixture, wherein the first mixing effort and a second mixing effort, resulting from mixing at least one excipient with the pre-blend mixture, form a blend suitable for direct compression and compressing the blend to form the tablet. One way of achieving the first mixing effort is to pre-blend for an extended period of time. The method allows for directly compressing the blend without the need for a granulation step or roller compression. One such active pharmaceutical ingredient susceptible to tackiness is ibuprofen.
摘要翻译: 形成片剂的方法包括以下步骤:将具有粘性的活性药物成分和混合添加剂预先混合以形成预混物混合物,其中第一混合力和第二混合力由 将至少一种赋形剂与预混物混合物混合,形成适于直接压缩和压缩混合物以形成片剂的共混物。 实现第一次混合努力的一种方式是预混合一段较长的时间。 该方法允许直接压缩共混物,而不需要造粒步骤或辊压缩。 易于粘性的一种这样的活性药物成分是布洛芬。
-
-
-
-
-